Sort
141,003 grants matching “cytokine”
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER
$958,687University Of North Carolina Chapel Hill · P60 · FY2000 · AR
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$958,404Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2019 · DA
Severe Malaria And Risk to The Brain (SMART Brain)
$958,384Chandy C. John · Indiana University Indianapolis · R01 · FY2024 · NS
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$958,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI
Excellence in Research: Role of the T3SS effector EseN of E. ictaluri in virulence and host immune response.
$958,309Lidiya P Dubytska · Southern University · · FY2021 · BIO
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$958,225D. Martin Watterson · Northwestern University At Chicago · U01 · FY2012 · AG
Design And Development Of Experimental Therapeutics
$958,195Nigel H. Greig · National Institute On Aging · ZIA · FY2013 · AG
Linking Antibody Cooperativity and Effector Cell Engagement
$958,020Guido Ferrari · Duke University · P01 · FY2023 · AI
2-HOBA for Treatment of Pulmonary Hypertension
$957,913John A Rathmacher · Mti Biotech, Inc. · R42 · FY2025 · HL
2-HOBA for Treatment of Pulmonary Hypertension
$957,913John A Rathmacher · Mti Biotech, Inc. · R42 · FY2024 · HL
Role of inflammation, innate resistance, and immunity in carcinogenesis
$957,864Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mechanisms of host-commensal interactions with Roseomonas mucosa that modulate innate immune responses to infection with Staphylococcus aureus and support homeostasis of human skin
$957,836Portia Gough · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
$957,734Lisa Tussing-Humphreys · University Of Illinois At Chicago · R01 · FY2025 · CA
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome
$957,638Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
$957,594Joe G. N. Garcia · Aqualung Therapeutics Corp. · R44 · FY2024 · HL
Core 3: Biocontainment Research Support Services Core
$957,509Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Linking Antibody Cooperativity and Effector Cell Engagement
$957,431Guido Ferrari · Duke University · P01 · FY2022 · AI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease
$957,389Ramya Ramaswami · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Integrative And Molecular Studies Of Pain And Pain Control
$957,023Michael J. Iadarola · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
Virus Clearance from the Central Nervous System
$956,718Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2011 · AI
Demystifying the antiviral activity of the IgG3+ antibody response
$956,707Galit Alter · Massachusetts General Hospital · R37 · FY2016 · AI
HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY)
$956,631Modupe Coker · University Of Pennsylvania · R01 · FY2024 · DE
Generation Of Cytokines And Arachidonic Acid In Mast Cells
$956,162Michael A Beaven · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Secretion Of Granules From Mast Cells
$956,162Michael A Beaven · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$956,049Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · AI